6-7079-901
EBV LMP-2 peptide CLGGLLTMV (HLA-A*0201)
Single peptide synthesized as presented by the MHC class I allele
EBV LMP2 peptide CLGGLLTMV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
| Form: | Lyophilized powder |
|---|---|
| Peptide Sequence: | CLGGLLTMV |
| Possible Application: | T cell stimulation |
| Purity: | > 85% |
| Sterility: | Sterile |
| MHC I Compatibility: | HLA-A*0201 |
| Storage: | -20 °C |
|---|---|
| Stability: | 12 months after shipping |
| Shipping: | Room temperature |
